Kyle E. Smoot
Impact in
-
- Multiple Sclerosis Research Studies
Papers in
-
- Multiple Sclerosis Research Studies 18
-
- Circadian rhythm and melatonin 1
- Co-authors
- STANLEY L. COHAN (13 shared papers)Elisabeth B. Lucassen (2 shared papers)Jason P. Mendoza (3 shared papers)Barry A. Hendin (1 shared paper)Anthony T. Reder (1 shared paper)Robin L. Avila (1 shared paper)Bianca Weinstock‐Guttman (1 shared paper)Pavle Repovic (3 shared papers)
- Journals
- Neurology (2 papers)Multiple Sclerosis and Related Disorders (2 papers)Advances in Therapy (2 papers)Multiple Sclerosis Journal (2 papers)The Lancet Neurology (1 paper)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Kyle E. Smoot
20 papers receiving 343 citations
Peers
Comparison fields: 5 of 40
- Pathology and Forensic Medicine 266
- Developmental Neuroscience 4
- Family Practice 3
- Neurology 7
- Immunology 13
Countries citing papers authored by Kyle E. Smoot
This map shows the geographic impact of Kyle E. Smoot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle E. Smoot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle E. Smoot more than expected).
Fields of papers citing papers by Kyle E. Smoot
This network shows the impact of papers produced by Kyle E. Smoot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle E. Smoot. The network helps show where Kyle E. Smoot may publish in the future.
Co-authors
The 25 scholars most cited alongside Kyle E. Smoot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 92 | |
| 2 | 2018 | 48 | |
| 3 | 2020 | 42 | |
| 4 | 2021 | 42 | |
| 5 | 2020 | 31 | |
| 6 | 2021 | 28 | |
| 7 | 2017 | 21 | |
| 8 | 2012 | 8 | |
| 9 | 2019 | 7 | |
| 10 | 2015 | 6 | |
| 11 | 2018 | 5 | |
| 12 | 2024 | 5 | |
| 13 | 2021 | 4 | |
| 14 | 2023 | 4 | |
| 15 | 2019 | 3 | |
| 16 | 2024 | 2 | |
| 17 | The Impact of Ocrelizumab on Immunoglobulin Levels and the Risk of Infection. | 2019 | 1 |
| 18 | Utilization, safety, and tolerability of ocrelizumab: year 2 data from the Providence Ocrelizumab Registry | 2019 | 1 |
| 19 | 2021 | 1 | |
| 20 | 2021 | 1 |
About Kyle E. Smoot
Kyle E. Smoot is a scholar working on Pathology and Forensic Medicine, Endocrine and Autonomic Systems, Rheumatology, Neurology and Immunology, having authored 21 papers that have together received 352 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (18 papers), Immunodeficiency and Autoimmune Disorders (1 paper), Circadian rhythm and melatonin (1 paper), Rheumatoid Arthritis Research and Therapies (1 paper), Sphingolipid Metabolism and Signaling (1 paper), Long-Term Effects of COVID-19 (1 paper), Cardiovascular Function and Risk Factors (1 paper) and Vasculitis and related conditions (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (266 citations), Developmental Neuroscience (4 citations), Family Practice (3 citations), Neurology (7 citations) and Immunology (13 citations). Kyle E. Smoot has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include STANLEY L. COHAN, Elisabeth B. Lucassen, Jason P. Mendoza, Barry A. Hendin, Anthony T. Reder, Robin L. Avila, Bianca Weinstock‐Guttman, Pavle Repovic, Leslie A. Meltzer and Jonathan Calkwood. Their work appears in journals such as Neurology, Multiple Sclerosis and Related Disorders, Advances in Therapy, Multiple Sclerosis Journal and The Lancet Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.